Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

285 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

NCT03938792

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • USF Health Morsani Center For Advanced Healthcare Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • Northwell Health HTC New Hyde Park, New York, United States
  • Washington Institute for Coagulation Seattle, Washington, United States
View all 62 locations
View Trial Details
Completed

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

NCT05147662

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Children, +9 more
Locations
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
  • Hospital de Niños Sor María Ludovica La Plata, Buenos Aires, Argentina
  • Instituo Hematología Arbesú Godoy Cruz, Mendoza Province, Argentina
  • Instituto de Hematología Dr. Rubén Dávoli Rosario, Santa Fe Province, Argentina
View all 18 locations
View Trial Details
Completed

Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A

NCT06579144

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Sobi Investigational Site Sofia, Bulgaria
  • Sobi Investigational Site Bonn, Germany
  • Sobi Investigational site Frankfurt, Germany
  • Sobi Investigational Site Milan, Italy
View Trial Details
Completed

Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants

NCT03315455

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • Xiangya Hospital of Centre-South University Changsha, China
  • Southern Medical University Nanfang Hospital Guangdong Province Guangzhou City, China
View all 13 locations
View Trial Details
Completed

Prophylaxis Regimen for Hemophilia A Patients

NCT05036278

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Dr. Akshat Jain - Loma Linda University Medical Center Loma Linda, California, United States
  • Loma Linda University Children's Hospital - Hematology / Oncology Loma Linda, California, United States
  • Luskin Orthopaedic Institute for Children Los Angeles, California, United States
  • University of Colorado | Renal Research Office Aurora, Colorado, United States
View Trial Details
Completed

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Clinical and Translational Research Unit (CTRU) Palo Alto, California, United States
  • Lucile Packard Childrens Hospital Palo Alto, California, United States
  • University of California, San Francisco - Outpatient Hematology Clinic San Francisco, California, United States
  • Stanford Health Care Stanford, California, United States
View all 75 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A

NCT04323098

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • University of California Davis Health Sacramento, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • The Royal Adelaide Hospital Adelaide, Australia
View Trial Details
Completed

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

NCT03061201

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • City of Hope Medical Center Duarte, California, United States
  • Midtown Ambulatory Care Center Sacramento, California, United States
  • UC Davis Ambulatory Care Clinic Sacramento, California, United States
View all 22 locations
View Trial Details
Completed

A Study of BAX 888 in Male Adults With Severe Hemophilia A

NCT03370172

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
View all 26 locations
View Trial Details

Related conditions